Nội dung text 22. STANDARDISATION OF VACCINES AND SERA.pdf
PHARMD GURU Page 2 The BCG albumin assay is designed to measure albumin directly without any pretreatment of samples, such as serum, plasma, urine, and biological preparations. It may also be used to measure effects of drugs and other compounds on albumin metabolism. It can be used for corvette or multiwall plate assays. The multiwall plate assay uses samples as small as 5 mL and can be readily automated as a high-throughput assay for thousands of samples per day. The procedure involves addition of a single working reagent and 5 minute incubation. The intensity of the color, measured at 620 nm, is directly proportional to the albumin concentration in the sample. SAFETY TEST: The abnormal toxicity test (ATT) using mice and guinea pigs is a non-specific safety test for vaccines, sera and immunoglobulins. Positive ATT's never resulted from the insufficient quality of a batch. On the other hand, vaccines causing adverse reactions In the target species were not identified by the ATT. ENDOTOXINS TEST: Twenty samples of commercial vaccines intended for administration to humans were assayed for the presence of bacterial endotoxins by using the Limulus amebocyte lysate test. Sixteen of the vaccines contained more than 0.1 mg of endotoxins per ml. These results suggest that at some stage of preparation, the vaccines have contained varying amounts of gram-negative bacteria and may indicate the presence of other bacterial products as well.